Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis

Niki Karachaliou, Imane Chaib, Andrés F. Cardona, Jordi Berenguer, Jillian Wilhelmina Paulina Bracht, Jie Yang, Xueting Cai, Zhigang Wang, Chunping Hu, Ana Drozdowskyj, Carles Codony, Jordi Codony Servat, Masaoki Ito, Ilaria Attili, Erika Aldeguer, Ana Giménez‐Capitán, July Rodríguez, Leonardo Rojas, Santiago Viteri, Miguel Ángel Molina‐Vila, Sai‐Hong Ignatius Ou, Morihito Okada, Tony Mok, Trever G. Bivona, Mayumi Ono, Jean Cui, Santiago Ramón y Cajal, Alex Frías, Peng Cao, Rafael Rosell

EBioMedicine, 2018

Instituto Oncológico Dr. Rosell, USP Institut Universitari Dexeus, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Foundation for Clinical and Applied Cancer Research, Nanjing University of Chinese Medicine, Jiangsu Provincial Academy of Traditional Chinese Medicine, Pivotal (Spain), Hiroshima University, Istituto Oncologico Veneto, Istituti di Ricovero e Cura a Carattere Scientifico, University of Padua, University of California, Irvine, Chinese University of Hong Kong, UCSF Helen Diller Family Comprehensive Cancer Center, Kyushu University, Vall d'Hebron Hospital Universitari, Danish Cancer Society, Institut Català d'Oncologia

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with EBioMedicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

Citations

View on Google Scholar

Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis

Abstract

Journal Details

Join JournalsHub

Welcome Back